Let’s keep an eye on opportunities both long and short in this volatile market.
On the long side, ProQR Therapeutics N.V. (PRQR) popped $1.70 to $17.48 on 464,200 shares Wednesday. The biotech company announced it received Fast Track designation from the Food and Drug Administration for one of its medicines treating severe genetic rare diseases. The move broke the stock out of its 2-month declining channel. Looking for a move next to next lateral resistance near $20.75.